Intrapartum recognition and management of fetal inflammation

Eur J Pediatr. 2026 Jan 15;185(2):81. doi: 10.1007/s00431-025-06738-w.ABSTRACTIntra-amniotic inflammation and infection are common intrapartum conditions at term and represent a major cause of fetal and neonatal morbidity independent of hypoxia. These conditions trigger the fetal inflammatory respon

E Elvira di Pasquo

The Effect of Telehomecare on Patients' Health-Related Quality of Life, Satisfaction, Disease Self-Management Skills, Provider Satisfaction, and Informal Caregiver Strain: Longitudinal Cohort and Cross-Sectional Study

JMIR Form Res. 2026 Jan 15;10:e70809. doi: 10.2196/70809.ABSTRACTBACKGROUND: Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are responsible for a significant amount of the economic and chronic disease burden that impacts the Ontario health system. Telehomecare, a home self-manag

T Troy Francis

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study

J Clin Oncol. 2026 Jan 15:JCO2501660. doi: 10.1200/JCO-25-01660. Online ahead of print.ABSTRACTPURPOSE: To evaluate the clinical benefit of extended endocrine therapy (eET) after 5 years of adjuvant treatment with luteinizing hormone-releasing hormone agonists (LHRHa) in premenopausal women with nod

C Carmine Valenza